Global Oligonucleotide Therapeutics Market Research Report 2026(Status and Outlook)
Oligonucleotide therapeutics are a class of precision medicines composed of short DNA or RNA sequences designed to specifically target and modulate the expression of genes involved in disease processes. These therapies can act by silencing, inhibiting, or correcting genetic abnormalities at the molecular level, offering a highly targeted approach to treat various conditions such as genetic disorders, cancers, and viral infections. Oligonucleotide therapeutics include antisense oligonucleotides, small interfering RNA (siRNA), and aptamers, and they represent a promising area of drug development due to their ability to address previously untreatable diseases.Key driver of the oligonucleotide therapeutics market is the growing prevalence of genetic and rare diseases that require precise and targeted treatment options. Advances in genomics and personalized medicine have fueled interest in oligonucleotide therapies, which can directly modulate gene expression and offer solutions for conditions that were previously difficult to treat. The success of approved oligonucleotide drugs, such as antisense oligonucleotides and siRNA therapies, has increased confidence in this field, leading to more investments and research in developing novel treatments for a wide range of diseases, including cancers and neurological disorders.One significant challenge in the oligonucleotide therapeutics market is the complexity of delivering these molecules effectively to target cells or tissues. Oligonucleotides are large, negatively charged molecules that face hurdles in stability, bioavailability, and efficient cellular uptake. Developing delivery systems that can ensure targeted and sustained delivery while minimizing immune responses or off-target effects remains a critical challenge. Additionally, the high costs associated with research, development, and manufacturing of oligonucleotide-based drugs pose financial challenges, limiting accessibility and widespread adoption, especially in resource-constrained healthcare settings.Europe is the largest consumption place, with a consumption market share nearly 44.61% in 2023. Following Europe, North Americas is the second largest consumption place with the consumption market share of 34.9%. The global key companies of oligonucleotide therapeutics include Pfizer, Moderna Therapeutics, BioNTech, Biogen, Alnylam, Sarepta Therapeutics, Jazz Pharmaceuticals, Nippon Shinyaku, Novartis, Sobi, Ionis Pharmaceuticals, etc. In 2023, the global top five players had a share approximately 97.87% in terms of revenue.
The global Oligonucleotide Therapeutics market size was estimated at USD 7536.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oligonucleotide Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oligonucleotide Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oligonucleotide Therapeutics market.
Global Oligonucleotide Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Market Segmentation (by Type)
Antisense Oligonucleotides (ASO)
siRNA
mRNA
Market Segmentation (by Application)
Neuromuscular Diseases
hATTR
COVID-19
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oligonucleotide Therapeutics Market
Overview of the regional outlook of the Oligonucleotide Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotide Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oligonucleotide Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Oligonucleotide Therapeutics market size was estimated at USD 7536.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oligonucleotide Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oligonucleotide Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oligonucleotide Therapeutics market.
Global Oligonucleotide Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Market Segmentation (by Type)
Antisense Oligonucleotides (ASO)
siRNA
mRNA
Market Segmentation (by Application)
Neuromuscular Diseases
hATTR
COVID-19
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oligonucleotide Therapeutics Market
Overview of the regional outlook of the Oligonucleotide Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotide Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oligonucleotide Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oligonucleotide Therapeutics
1.2 Key Market Segments
1.2.1 Oligonucleotide Therapeutics Segment by Type
1.2.2 Oligonucleotide Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OLIGONUCLEOTIDE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oligonucleotide Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oligonucleotide Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OLIGONUCLEOTIDE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oligonucleotide Therapeutics Product Life Cycle
3.3 Global Oligonucleotide Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Oligonucleotide Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Oligonucleotide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oligonucleotide Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oligonucleotide Therapeutics Market Competitive Situation and Trends
3.8.1 Oligonucleotide Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oligonucleotide Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Oligonucleotide Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OLIGONUCLEOTIDE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oligonucleotide Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oligonucleotide Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 OLIGONUCLEOTIDE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Oligonucleotide Therapeutics Market Size by Type (2020-2025)
6.4 Global Oligonucleotide Therapeutics Price by Type (2020-2025)
7 OLIGONUCLEOTIDE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide Therapeutics Market Sales by Application (2020-2025)
7.3 Global Oligonucleotide Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Oligonucleotide Therapeutics Sales Growth Rate by Application (2020-2025)
8 OLIGONUCLEOTIDE THERAPEUTICS MARKET SALES BY REGION
8.1 Global Oligonucleotide Therapeutics Sales by Region
8.1.1 Global Oligonucleotide Therapeutics Sales by Region
8.1.2 Global Oligonucleotide Therapeutics Sales Market Share by Region
8.2 Global Oligonucleotide Therapeutics Market Size by Region
8.2.1 Global Oligonucleotide Therapeutics Market Size by Region
8.2.2 Global Oligonucleotide Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Oligonucleotide Therapeutics Sales by Country
8.3.2 North America Oligonucleotide Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oligonucleotide Therapeutics Sales by Country
8.4.2 Europe Oligonucleotide Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oligonucleotide Therapeutics Sales by Region
8.5.2 Asia Pacific Oligonucleotide Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oligonucleotide Therapeutics Sales by Country
8.6.2 South America Oligonucleotide Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oligonucleotide Therapeutics Sales by Region
8.7.2 Middle East and Africa Oligonucleotide Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OLIGONUCLEOTIDE THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Oligonucleotide Therapeutics by Region(2020-2025)
9.2 Global Oligonucleotide Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oligonucleotide Therapeutics Production
9.4.1 North America Oligonucleotide Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oligonucleotide Therapeutics Production
9.5.1 Europe Oligonucleotide Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oligonucleotide Therapeutics Production (2020-2025)
9.6.1 Japan Oligonucleotide Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oligonucleotide Therapeutics Production (2020-2025)
9.7.1 China Oligonucleotide Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics Basic Information
10.1.2 Sarepta Therapeutics Oligonucleotide Therapeutics Product Overview
10.1.3 Sarepta Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 Ionis Pharmaceuticals
10.2.1 Ionis Pharmaceuticals Basic Information
10.2.2 Ionis Pharmaceuticals Oligonucleotide Therapeutics Product Overview
10.2.3 Ionis Pharmaceuticals Oligonucleotide Therapeutics Product Market Performance
10.2.4 Ionis Pharmaceuticals Business Overview
10.2.5 Ionis Pharmaceuticals SWOT Analysis
10.2.6 Ionis Pharmaceuticals Recent Developments
10.3 Alnylam
10.3.1 Alnylam Basic Information
10.3.2 Alnylam Oligonucleotide Therapeutics Product Overview
10.3.3 Alnylam Oligonucleotide Therapeutics Product Market Performance
10.3.4 Alnylam Business Overview
10.3.5 Alnylam SWOT Analysis
10.3.6 Alnylam Recent Developments
10.4 Biogen
10.4.1 Biogen Basic Information
10.4.2 Biogen Oligonucleotide Therapeutics Product Overview
10.4.3 Biogen Oligonucleotide Therapeutics Product Market Performance
10.4.4 Biogen Business Overview
10.4.5 Biogen Recent Developments
10.5 Nippon Shinyaku
10.5.1 Nippon Shinyaku Basic Information
10.5.2 Nippon Shinyaku Oligonucleotide Therapeutics Product Overview
10.5.3 Nippon Shinyaku Oligonucleotide Therapeutics Product Market Performance
10.5.4 Nippon Shinyaku Business Overview
10.5.5 Nippon Shinyaku Recent Developments
10.6 Sobi
10.6.1 Sobi Basic Information
10.6.2 Sobi Oligonucleotide Therapeutics Product Overview
10.6.3 Sobi Oligonucleotide Therapeutics Product Market Performance
10.6.4 Sobi Business Overview
10.6.5 Sobi Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Oligonucleotide Therapeutics Product Overview
10.7.3 Novartis Oligonucleotide Therapeutics Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 BioNTech
10.8.1 BioNTech Basic Information
10.8.2 BioNTech Oligonucleotide Therapeutics Product Overview
10.8.3 BioNTech Oligonucleotide Therapeutics Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Pfizer
10.9.1 Pfizer Basic Information
10.9.2 Pfizer Oligonucleotide Therapeutics Product Overview
10.9.3 Pfizer Oligonucleotide Therapeutics Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Moderna Therapeutics
10.10.1 Moderna Therapeutics Basic Information
10.10.2 Moderna Therapeutics Oligonucleotide Therapeutics Product Overview
10.10.3 Moderna Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.10.4 Moderna Therapeutics Business Overview
10.10.5 Moderna Therapeutics Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Basic Information
10.11.2 Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Overview
10.11.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 CureVac
10.12.1 CureVac Basic Information
10.12.2 CureVac Oligonucleotide Therapeutics Product Overview
10.12.3 CureVac Oligonucleotide Therapeutics Product Market Performance
10.12.4 CureVac Business Overview
10.12.5 CureVac Recent Developments
10.13 Regulus Therapeutics
10.13.1 Regulus Therapeutics Basic Information
10.13.2 Regulus Therapeutics Oligonucleotide Therapeutics Product Overview
10.13.3 Regulus Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.13.4 Regulus Therapeutics Business Overview
10.13.5 Regulus Therapeutics Recent Developments
10.14 ProQR
10.14.1 ProQR Basic Information
10.14.2 ProQR Oligonucleotide Therapeutics Product Overview
10.14.3 ProQR Oligonucleotide Therapeutics Product Market Performance
10.14.4 ProQR Business Overview
10.14.5 ProQR Recent Developments
10.15 Secarna
10.15.1 Secarna Basic Information
10.15.2 Secarna Oligonucleotide Therapeutics Product Overview
10.15.3 Secarna Oligonucleotide Therapeutics Product Market Performance
10.15.4 Secarna Business Overview
10.15.5 Secarna Recent Developments
10.16 MiNA Therapeutics
10.16.1 MiNA Therapeutics Basic Information
10.16.2 MiNA Therapeutics Oligonucleotide Therapeutics Product Overview
10.16.3 MiNA Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.16.4 MiNA Therapeutics Business Overview
10.16.5 MiNA Therapeutics Recent Developments
10.17 Sylentis
10.17.1 Sylentis Basic Information
10.17.2 Sylentis Oligonucleotide Therapeutics Product Overview
10.17.3 Sylentis Oligonucleotide Therapeutics Product Market Performance
10.17.4 Sylentis Business Overview
10.17.5 Sylentis Recent Developments
10.18 Arrowhead
10.18.1 Arrowhead Basic Information
10.18.2 Arrowhead Oligonucleotide Therapeutics Product Overview
10.18.3 Arrowhead Oligonucleotide Therapeutics Product Market Performance
10.18.4 Arrowhead Business Overview
10.18.5 Arrowhead Recent Developments
10.19 Silence Therapeutics
10.19.1 Silence Therapeutics Basic Information
10.19.2 Silence Therapeutics Oligonucleotide Therapeutics Product Overview
10.19.3 Silence Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.19.4 Silence Therapeutics Business Overview
10.19.5 Silence Therapeutics Recent Developments
10.20 Dicerna
10.20.1 Dicerna Basic Information
10.20.2 Dicerna Oligonucleotide Therapeutics Product Overview
10.20.3 Dicerna Oligonucleotide Therapeutics Product Market Performance
10.20.4 Dicerna Business Overview
10.20.5 Dicerna Recent Developments
11 OLIGONUCLEOTIDE THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Oligonucleotide Therapeutics Market Size Forecast
11.2 Global Oligonucleotide Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oligonucleotide Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Oligonucleotide Therapeutics Market Size Forecast by Region
11.2.4 South America Oligonucleotide Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oligonucleotide Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oligonucleotide Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oligonucleotide Therapeutics by Type (2026-2035)
12.1.2 Global Oligonucleotide Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oligonucleotide Therapeutics by Type (2026-2035)
12.2 Global Oligonucleotide Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Oligonucleotide Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Oligonucleotide Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oligonucleotide Therapeutics
1.2 Key Market Segments
1.2.1 Oligonucleotide Therapeutics Segment by Type
1.2.2 Oligonucleotide Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OLIGONUCLEOTIDE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oligonucleotide Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oligonucleotide Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OLIGONUCLEOTIDE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oligonucleotide Therapeutics Product Life Cycle
3.3 Global Oligonucleotide Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Oligonucleotide Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Oligonucleotide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oligonucleotide Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oligonucleotide Therapeutics Market Competitive Situation and Trends
3.8.1 Oligonucleotide Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oligonucleotide Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Oligonucleotide Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OLIGONUCLEOTIDE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oligonucleotide Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oligonucleotide Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 OLIGONUCLEOTIDE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Oligonucleotide Therapeutics Market Size by Type (2020-2025)
6.4 Global Oligonucleotide Therapeutics Price by Type (2020-2025)
7 OLIGONUCLEOTIDE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide Therapeutics Market Sales by Application (2020-2025)
7.3 Global Oligonucleotide Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Oligonucleotide Therapeutics Sales Growth Rate by Application (2020-2025)
8 OLIGONUCLEOTIDE THERAPEUTICS MARKET SALES BY REGION
8.1 Global Oligonucleotide Therapeutics Sales by Region
8.1.1 Global Oligonucleotide Therapeutics Sales by Region
8.1.2 Global Oligonucleotide Therapeutics Sales Market Share by Region
8.2 Global Oligonucleotide Therapeutics Market Size by Region
8.2.1 Global Oligonucleotide Therapeutics Market Size by Region
8.2.2 Global Oligonucleotide Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Oligonucleotide Therapeutics Sales by Country
8.3.2 North America Oligonucleotide Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oligonucleotide Therapeutics Sales by Country
8.4.2 Europe Oligonucleotide Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oligonucleotide Therapeutics Sales by Region
8.5.2 Asia Pacific Oligonucleotide Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oligonucleotide Therapeutics Sales by Country
8.6.2 South America Oligonucleotide Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oligonucleotide Therapeutics Sales by Region
8.7.2 Middle East and Africa Oligonucleotide Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OLIGONUCLEOTIDE THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Oligonucleotide Therapeutics by Region(2020-2025)
9.2 Global Oligonucleotide Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oligonucleotide Therapeutics Production
9.4.1 North America Oligonucleotide Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oligonucleotide Therapeutics Production
9.5.1 Europe Oligonucleotide Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oligonucleotide Therapeutics Production (2020-2025)
9.6.1 Japan Oligonucleotide Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oligonucleotide Therapeutics Production (2020-2025)
9.7.1 China Oligonucleotide Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Oligonucleotide Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics Basic Information
10.1.2 Sarepta Therapeutics Oligonucleotide Therapeutics Product Overview
10.1.3 Sarepta Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 Ionis Pharmaceuticals
10.2.1 Ionis Pharmaceuticals Basic Information
10.2.2 Ionis Pharmaceuticals Oligonucleotide Therapeutics Product Overview
10.2.3 Ionis Pharmaceuticals Oligonucleotide Therapeutics Product Market Performance
10.2.4 Ionis Pharmaceuticals Business Overview
10.2.5 Ionis Pharmaceuticals SWOT Analysis
10.2.6 Ionis Pharmaceuticals Recent Developments
10.3 Alnylam
10.3.1 Alnylam Basic Information
10.3.2 Alnylam Oligonucleotide Therapeutics Product Overview
10.3.3 Alnylam Oligonucleotide Therapeutics Product Market Performance
10.3.4 Alnylam Business Overview
10.3.5 Alnylam SWOT Analysis
10.3.6 Alnylam Recent Developments
10.4 Biogen
10.4.1 Biogen Basic Information
10.4.2 Biogen Oligonucleotide Therapeutics Product Overview
10.4.3 Biogen Oligonucleotide Therapeutics Product Market Performance
10.4.4 Biogen Business Overview
10.4.5 Biogen Recent Developments
10.5 Nippon Shinyaku
10.5.1 Nippon Shinyaku Basic Information
10.5.2 Nippon Shinyaku Oligonucleotide Therapeutics Product Overview
10.5.3 Nippon Shinyaku Oligonucleotide Therapeutics Product Market Performance
10.5.4 Nippon Shinyaku Business Overview
10.5.5 Nippon Shinyaku Recent Developments
10.6 Sobi
10.6.1 Sobi Basic Information
10.6.2 Sobi Oligonucleotide Therapeutics Product Overview
10.6.3 Sobi Oligonucleotide Therapeutics Product Market Performance
10.6.4 Sobi Business Overview
10.6.5 Sobi Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Oligonucleotide Therapeutics Product Overview
10.7.3 Novartis Oligonucleotide Therapeutics Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 BioNTech
10.8.1 BioNTech Basic Information
10.8.2 BioNTech Oligonucleotide Therapeutics Product Overview
10.8.3 BioNTech Oligonucleotide Therapeutics Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Pfizer
10.9.1 Pfizer Basic Information
10.9.2 Pfizer Oligonucleotide Therapeutics Product Overview
10.9.3 Pfizer Oligonucleotide Therapeutics Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Moderna Therapeutics
10.10.1 Moderna Therapeutics Basic Information
10.10.2 Moderna Therapeutics Oligonucleotide Therapeutics Product Overview
10.10.3 Moderna Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.10.4 Moderna Therapeutics Business Overview
10.10.5 Moderna Therapeutics Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Basic Information
10.11.2 Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Overview
10.11.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 CureVac
10.12.1 CureVac Basic Information
10.12.2 CureVac Oligonucleotide Therapeutics Product Overview
10.12.3 CureVac Oligonucleotide Therapeutics Product Market Performance
10.12.4 CureVac Business Overview
10.12.5 CureVac Recent Developments
10.13 Regulus Therapeutics
10.13.1 Regulus Therapeutics Basic Information
10.13.2 Regulus Therapeutics Oligonucleotide Therapeutics Product Overview
10.13.3 Regulus Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.13.4 Regulus Therapeutics Business Overview
10.13.5 Regulus Therapeutics Recent Developments
10.14 ProQR
10.14.1 ProQR Basic Information
10.14.2 ProQR Oligonucleotide Therapeutics Product Overview
10.14.3 ProQR Oligonucleotide Therapeutics Product Market Performance
10.14.4 ProQR Business Overview
10.14.5 ProQR Recent Developments
10.15 Secarna
10.15.1 Secarna Basic Information
10.15.2 Secarna Oligonucleotide Therapeutics Product Overview
10.15.3 Secarna Oligonucleotide Therapeutics Product Market Performance
10.15.4 Secarna Business Overview
10.15.5 Secarna Recent Developments
10.16 MiNA Therapeutics
10.16.1 MiNA Therapeutics Basic Information
10.16.2 MiNA Therapeutics Oligonucleotide Therapeutics Product Overview
10.16.3 MiNA Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.16.4 MiNA Therapeutics Business Overview
10.16.5 MiNA Therapeutics Recent Developments
10.17 Sylentis
10.17.1 Sylentis Basic Information
10.17.2 Sylentis Oligonucleotide Therapeutics Product Overview
10.17.3 Sylentis Oligonucleotide Therapeutics Product Market Performance
10.17.4 Sylentis Business Overview
10.17.5 Sylentis Recent Developments
10.18 Arrowhead
10.18.1 Arrowhead Basic Information
10.18.2 Arrowhead Oligonucleotide Therapeutics Product Overview
10.18.3 Arrowhead Oligonucleotide Therapeutics Product Market Performance
10.18.4 Arrowhead Business Overview
10.18.5 Arrowhead Recent Developments
10.19 Silence Therapeutics
10.19.1 Silence Therapeutics Basic Information
10.19.2 Silence Therapeutics Oligonucleotide Therapeutics Product Overview
10.19.3 Silence Therapeutics Oligonucleotide Therapeutics Product Market Performance
10.19.4 Silence Therapeutics Business Overview
10.19.5 Silence Therapeutics Recent Developments
10.20 Dicerna
10.20.1 Dicerna Basic Information
10.20.2 Dicerna Oligonucleotide Therapeutics Product Overview
10.20.3 Dicerna Oligonucleotide Therapeutics Product Market Performance
10.20.4 Dicerna Business Overview
10.20.5 Dicerna Recent Developments
11 OLIGONUCLEOTIDE THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Oligonucleotide Therapeutics Market Size Forecast
11.2 Global Oligonucleotide Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oligonucleotide Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Oligonucleotide Therapeutics Market Size Forecast by Region
11.2.4 South America Oligonucleotide Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oligonucleotide Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oligonucleotide Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oligonucleotide Therapeutics by Type (2026-2035)
12.1.2 Global Oligonucleotide Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oligonucleotide Therapeutics by Type (2026-2035)
12.2 Global Oligonucleotide Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Oligonucleotide Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Oligonucleotide Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oligonucleotide Therapeutics Market Size by Type (M USD)
Table 4. Global Oligonucleotide Therapeutics Market Size by Application
Table 5. Oligonucleotide Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Oligonucleotide Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oligonucleotide Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oligonucleotide Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oligonucleotide Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics as of 2025)
Table 11. Global Market Oligonucleotide Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oligonucleotide Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotide Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oligonucleotide Therapeutics Sales by Type (K MT)
Table 27. Global Oligonucleotide Therapeutics Market Size by Type (M USD)
Table 28. Global Oligonucleotide Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Oligonucleotide Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Oligonucleotide Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Oligonucleotide Therapeutics Market Share by Type (2020-2025)
Table 32. Global Oligonucleotide Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Oligonucleotide Therapeutics Sales (K MT) by Application
Table 34. Global Oligonucleotide Therapeutics Market Size by Application
Table 35. Global Oligonucleotide Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Oligonucleotide Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Oligonucleotide Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oligonucleotide Therapeutics Market Share by Application (2020-2025)
Table 39. Global Oligonucleotide Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Oligonucleotide Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Oligonucleotide Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Oligonucleotide Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oligonucleotide Therapeutics Market Size by Region (2020-2025)
Table 44. North America Oligonucleotide Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Oligonucleotide Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oligonucleotide Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oligonucleotide Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oligonucleotide Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oligonucleotide Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oligonucleotide Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Oligonucleotide Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oligonucleotide Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oligonucleotide Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oligonucleotide Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Oligonucleotide Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oligonucleotide Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sarepta Therapeutics Basic Information
Table 63. Sarepta Therapeutics Oligonucleotide Therapeutics Product Overview
Table 64. Sarepta Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sarepta Therapeutics Business Overview
Table 66. Sarepta Therapeutics SWOT Analysis
Table 67. Sarepta Therapeutics Recent Developments
Table 68. Ionis Pharmaceuticals Basic Information
Table 69. Ionis Pharmaceuticals Oligonucleotide Therapeutics Product Overview
Table 70. Ionis Pharmaceuticals Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Ionis Pharmaceuticals Business Overview
Table 72. Ionis Pharmaceuticals SWOT Analysis
Table 73. Ionis Pharmaceuticals Recent Developments
Table 74. Alnylam Basic Information
Table 75. Alnylam Oligonucleotide Therapeutics Product Overview
Table 76. Alnylam Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Alnylam Business Overview
Table 78. Alnylam SWOT Analysis
Table 79. Alnylam Recent Developments
Table 80. Biogen Basic Information
Table 81. Biogen Oligonucleotide Therapeutics Product Overview
Table 82. Biogen Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Biogen Business Overview
Table 84. Biogen Recent Developments
Table 85. Nippon Shinyaku Basic Information
Table 86. Nippon Shinyaku Oligonucleotide Therapeutics Product Overview
Table 87. Nippon Shinyaku Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Nippon Shinyaku Business Overview
Table 89. Nippon Shinyaku Recent Developments
Table 90. Sobi Basic Information
Table 91. Sobi Oligonucleotide Therapeutics Product Overview
Table 92. Sobi Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sobi Business Overview
Table 94. Sobi Recent Developments
Table 95. Novartis Basic Information
Table 96. Novartis Oligonucleotide Therapeutics Product Overview
Table 97. Novartis Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Novartis Business Overview
Table 99. Novartis Recent Developments
Table 100. BioNTech Basic Information
Table 101. BioNTech Oligonucleotide Therapeutics Product Overview
Table 102. BioNTech Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BioNTech Business Overview
Table 104. BioNTech Recent Developments
Table 105. Pfizer Basic Information
Table 106. Pfizer Oligonucleotide Therapeutics Product Overview
Table 107. Pfizer Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Pfizer Business Overview
Table 109. Pfizer Recent Developments
Table 110. Moderna Therapeutics Basic Information
Table 111. Moderna Therapeutics Oligonucleotide Therapeutics Product Overview
Table 112. Moderna Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Moderna Therapeutics Business Overview
Table 114. Moderna Therapeutics Recent Developments
Table 115. Jazz Pharmaceuticals Basic Information
Table 116. Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Overview
Table 117. Jazz Pharmaceuticals Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Jazz Pharmaceuticals Business Overview
Table 119. Jazz Pharmaceuticals Recent Developments
Table 120. CureVac Basic Information
Table 121. CureVac Oligonucleotide Therapeutics Product Overview
Table 122. CureVac Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. CureVac Business Overview
Table 124. CureVac Recent Developments
Table 125. Regulus Therapeutics Basic Information
Table 126. Regulus Therapeutics Oligonucleotide Therapeutics Product Overview
Table 127. Regulus Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Regulus Therapeutics Business Overview
Table 129. Regulus Therapeutics Recent Developments
Table 130. ProQR Basic Information
Table 131. ProQR Oligonucleotide Therapeutics Product Overview
Table 132. ProQR Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. ProQR Business Overview
Table 134. ProQR Recent Developments
Table 135. Secarna Basic Information
Table 136. Secarna Oligonucleotide Therapeutics Product Overview
Table 137. Secarna Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Secarna Business Overview
Table 139. Secarna Recent Developments
Table 140. MiNA Therapeutics Basic Information
Table 141. MiNA Therapeutics Oligonucleotide Therapeutics Product Overview
Table 142. MiNA Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. MiNA Therapeutics Business Overview
Table 144. MiNA Therapeutics Recent Developments
Table 145. Sylentis Basic Information
Table 146. Sylentis Oligonucleotide Therapeutics Product Overview
Table 147. Sylentis Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Sylentis Business Overview
Table 149. Sylentis Recent Developments
Table 150. Arrowhead Basic Information
Table 151. Arrowhead Oligonucleotide Therapeutics Product Overview
Table 152. Arrowhead Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Arrowhead Business Overview
Table 154. Arrowhead Recent Developments
Table 155. Silence Therapeutics Basic Information
Table 156. Silence Therapeutics Oligonucleotide Therapeutics Product Overview
Table 157. Silence Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Silence Therapeutics Business Overview
Table 159. Silence Therapeutics Recent Developments
Table 160. Dicerna Basic Information
Table 161. Dicerna Oligonucleotide Therapeutics Product Overview
Table 162. Dicerna Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Dicerna Business Overview
Table 164. Dicerna Recent Developments
Table 165. Global Oligonucleotide Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Oligonucleotide Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Oligonucleotide Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Oligonucleotide Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Oligonucleotide Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Oligonucleotide Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Oligonucleotide Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Oligonucleotide Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Oligonucleotide Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Oligonucleotide Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Oligonucleotide Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Oligonucleotide Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Oligonucleotide Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Oligonucleotide Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Oligonucleotide Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Oligonucleotide Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Oligonucleotide Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oligonucleotide Therapeutics Market Size by Type (M USD)
Table 4. Global Oligonucleotide Therapeutics Market Size by Application
Table 5. Oligonucleotide Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Oligonucleotide Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oligonucleotide Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oligonucleotide Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oligonucleotide Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics as of 2025)
Table 11. Global Market Oligonucleotide Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oligonucleotide Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotide Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oligonucleotide Therapeutics Sales by Type (K MT)
Table 27. Global Oligonucleotide Therapeutics Market Size by Type (M USD)
Table 28. Global Oligonucleotide Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Oligonucleotide Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Oligonucleotide Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Oligonucleotide Therapeutics Market Share by Type (2020-2025)
Table 32. Global Oligonucleotide Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Oligonucleotide Therapeutics Sales (K MT) by Application
Table 34. Global Oligonucleotide Therapeutics Market Size by Application
Table 35. Global Oligonucleotide Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Oligonucleotide Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Oligonucleotide Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oligonucleotide Therapeutics Market Share by Application (2020-2025)
Table 39. Global Oligonucleotide Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Oligonucleotide Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Oligonucleotide Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Oligonucleotide Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oligonucleotide Therapeutics Market Size by Region (2020-2025)
Table 44. North America Oligonucleotide Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Oligonucleotide Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oligonucleotide Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oligonucleotide Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oligonucleotide Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oligonucleotide Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oligonucleotide Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Oligonucleotide Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oligonucleotide Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oligonucleotide Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oligonucleotide Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Oligonucleotide Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oligonucleotide Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oligonucleotide Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sarepta Therapeutics Basic Information
Table 63. Sarepta Therapeutics Oligonucleotide Therapeutics Product Overview
Table 64. Sarepta Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sarepta Therapeutics Business Overview
Table 66. Sarepta Therapeutics SWOT Analysis
Table 67. Sarepta Therapeutics Recent Developments
Table 68. Ionis Pharmaceuticals Basic Information
Table 69. Ionis Pharmaceuticals Oligonucleotide Therapeutics Product Overview
Table 70. Ionis Pharmaceuticals Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Ionis Pharmaceuticals Business Overview
Table 72. Ionis Pharmaceuticals SWOT Analysis
Table 73. Ionis Pharmaceuticals Recent Developments
Table 74. Alnylam Basic Information
Table 75. Alnylam Oligonucleotide Therapeutics Product Overview
Table 76. Alnylam Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Alnylam Business Overview
Table 78. Alnylam SWOT Analysis
Table 79. Alnylam Recent Developments
Table 80. Biogen Basic Information
Table 81. Biogen Oligonucleotide Therapeutics Product Overview
Table 82. Biogen Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Biogen Business Overview
Table 84. Biogen Recent Developments
Table 85. Nippon Shinyaku Basic Information
Table 86. Nippon Shinyaku Oligonucleotide Therapeutics Product Overview
Table 87. Nippon Shinyaku Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Nippon Shinyaku Business Overview
Table 89. Nippon Shinyaku Recent Developments
Table 90. Sobi Basic Information
Table 91. Sobi Oligonucleotide Therapeutics Product Overview
Table 92. Sobi Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sobi Business Overview
Table 94. Sobi Recent Developments
Table 95. Novartis Basic Information
Table 96. Novartis Oligonucleotide Therapeutics Product Overview
Table 97. Novartis Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Novartis Business Overview
Table 99. Novartis Recent Developments
Table 100. BioNTech Basic Information
Table 101. BioNTech Oligonucleotide Therapeutics Product Overview
Table 102. BioNTech Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BioNTech Business Overview
Table 104. BioNTech Recent Developments
Table 105. Pfizer Basic Information
Table 106. Pfizer Oligonucleotide Therapeutics Product Overview
Table 107. Pfizer Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Pfizer Business Overview
Table 109. Pfizer Recent Developments
Table 110. Moderna Therapeutics Basic Information
Table 111. Moderna Therapeutics Oligonucleotide Therapeutics Product Overview
Table 112. Moderna Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Moderna Therapeutics Business Overview
Table 114. Moderna Therapeutics Recent Developments
Table 115. Jazz Pharmaceuticals Basic Information
Table 116. Jazz Pharmaceuticals Oligonucleotide Therapeutics Product Overview
Table 117. Jazz Pharmaceuticals Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Jazz Pharmaceuticals Business Overview
Table 119. Jazz Pharmaceuticals Recent Developments
Table 120. CureVac Basic Information
Table 121. CureVac Oligonucleotide Therapeutics Product Overview
Table 122. CureVac Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. CureVac Business Overview
Table 124. CureVac Recent Developments
Table 125. Regulus Therapeutics Basic Information
Table 126. Regulus Therapeutics Oligonucleotide Therapeutics Product Overview
Table 127. Regulus Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Regulus Therapeutics Business Overview
Table 129. Regulus Therapeutics Recent Developments
Table 130. ProQR Basic Information
Table 131. ProQR Oligonucleotide Therapeutics Product Overview
Table 132. ProQR Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. ProQR Business Overview
Table 134. ProQR Recent Developments
Table 135. Secarna Basic Information
Table 136. Secarna Oligonucleotide Therapeutics Product Overview
Table 137. Secarna Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Secarna Business Overview
Table 139. Secarna Recent Developments
Table 140. MiNA Therapeutics Basic Information
Table 141. MiNA Therapeutics Oligonucleotide Therapeutics Product Overview
Table 142. MiNA Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. MiNA Therapeutics Business Overview
Table 144. MiNA Therapeutics Recent Developments
Table 145. Sylentis Basic Information
Table 146. Sylentis Oligonucleotide Therapeutics Product Overview
Table 147. Sylentis Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Sylentis Business Overview
Table 149. Sylentis Recent Developments
Table 150. Arrowhead Basic Information
Table 151. Arrowhead Oligonucleotide Therapeutics Product Overview
Table 152. Arrowhead Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Arrowhead Business Overview
Table 154. Arrowhead Recent Developments
Table 155. Silence Therapeutics Basic Information
Table 156. Silence Therapeutics Oligonucleotide Therapeutics Product Overview
Table 157. Silence Therapeutics Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Silence Therapeutics Business Overview
Table 159. Silence Therapeutics Recent Developments
Table 160. Dicerna Basic Information
Table 161. Dicerna Oligonucleotide Therapeutics Product Overview
Table 162. Dicerna Oligonucleotide Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Dicerna Business Overview
Table 164. Dicerna Recent Developments
Table 165. Global Oligonucleotide Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Oligonucleotide Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Oligonucleotide Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Oligonucleotide Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Oligonucleotide Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Oligonucleotide Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Oligonucleotide Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Oligonucleotide Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Oligonucleotide Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Oligonucleotide Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Oligonucleotide Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Oligonucleotide Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Oligonucleotide Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Oligonucleotide Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Oligonucleotide Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Oligonucleotide Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Oligonucleotide Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oligonucleotide Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotide Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Oligonucleotide Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Oligonucleotide Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotide Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oligonucleotide Therapeutics Product Life Cycle
Figure 13. Oligonucleotide Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Oligonucleotide Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Oligonucleotide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oligonucleotide Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Oligonucleotide Therapeutics
Figure 19. Global Oligonucleotide Therapeutics Market PEST Analysis
Figure 20. Global Oligonucleotide Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oligonucleotide Therapeutics Market Share by Type
Figure 27. Sales Market Share of Oligonucleotide Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Oligonucleotide Therapeutics by Type in 2025
Figure 29. Market Share of Oligonucleotide Therapeutics by Type (2020-2025)
Figure 30. Market Share of Oligonucleotide Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oligonucleotide Therapeutics Market Share by Application
Figure 33. Global Oligonucleotide Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Oligonucleotide Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Oligonucleotide Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Oligonucleotide Therapeutics Market Share by Application in 2025
Figure 37. Global Oligonucleotide Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oligonucleotide Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Oligonucleotide Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oligonucleotide Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oligonucleotide Therapeutics Market Size by Country in 2024
Figure 45. U.S. Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oligonucleotide Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oligonucleotide Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oligonucleotide Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oligonucleotide Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oligonucleotide Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oligonucleotide Therapeutics Market Size by Country in 2024
Figure 55. Germany Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oligonucleotide Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oligonucleotide Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oligonucleotide Therapeutics Market Size by Region in 2024
Figure 68. China Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oligonucleotide Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Oligonucleotide Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Oligonucleotide Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Oligonucleotide Therapeutics Market Size by Country in 2024
Figure 82. Brazil Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oligonucleotide Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oligonucleotide Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oligonucleotide Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oligonucleotide Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oligonucleotide Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Oligonucleotide Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oligonucleotide Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oligonucleotide Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oligonucleotide Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oligonucleotide Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oligonucleotide Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oligonucleotide Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oligonucleotide Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Oligonucleotide Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Oligonucleotide Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Oligonucleotide Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotide Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Oligonucleotide Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Oligonucleotide Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotide Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oligonucleotide Therapeutics Product Life Cycle
Figure 13. Oligonucleotide Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Oligonucleotide Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Oligonucleotide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oligonucleotide Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Oligonucleotide Therapeutics
Figure 19. Global Oligonucleotide Therapeutics Market PEST Analysis
Figure 20. Global Oligonucleotide Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oligonucleotide Therapeutics Market Share by Type
Figure 27. Sales Market Share of Oligonucleotide Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Oligonucleotide Therapeutics by Type in 2025
Figure 29. Market Share of Oligonucleotide Therapeutics by Type (2020-2025)
Figure 30. Market Share of Oligonucleotide Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oligonucleotide Therapeutics Market Share by Application
Figure 33. Global Oligonucleotide Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Oligonucleotide Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Oligonucleotide Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Oligonucleotide Therapeutics Market Share by Application in 2025
Figure 37. Global Oligonucleotide Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oligonucleotide Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Oligonucleotide Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oligonucleotide Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oligonucleotide Therapeutics Market Size by Country in 2024
Figure 45. U.S. Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oligonucleotide Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oligonucleotide Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oligonucleotide Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oligonucleotide Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oligonucleotide Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oligonucleotide Therapeutics Market Size by Country in 2024
Figure 55. Germany Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oligonucleotide Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oligonucleotide Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oligonucleotide Therapeutics Market Size by Region in 2024
Figure 68. China Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oligonucleotide Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Oligonucleotide Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Oligonucleotide Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Oligonucleotide Therapeutics Market Size by Country in 2024
Figure 82. Brazil Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oligonucleotide Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oligonucleotide Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oligonucleotide Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oligonucleotide Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oligonucleotide Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oligonucleotide Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oligonucleotide Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Oligonucleotide Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oligonucleotide Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oligonucleotide Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oligonucleotide Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oligonucleotide Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oligonucleotide Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oligonucleotide Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oligonucleotide Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Oligonucleotide Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Oligonucleotide Therapeutics Market Share Forecast by Application (2026-2035)
